Literature DB >> 26260689

Marker vaccine potential of foot-and-mouth disease virus with large deletion in the non-structural proteins 3A and 3B.

Jitendra K Biswal1, Saravanan Subramaniam2, Rajeev Ranjan2, Gaurav K Sharma2, Jyoti Misri3, Bramhadev Pattnaik4.   

Abstract

Foot-and-mouth disease (FMD) is a highly contagious, economically important disease of transboundary importance. Regular vaccination with chemically inactivated FMD vaccine is the major means of controlling the disease in endemic countries like India. However, the traditional inactivated vaccines may sometimes contain traces of FMD viral (FMDV) non-structural protein (NSP), therefore, interfering with the NSP-based serological discrimination between infected and vaccinated animals. The availability of marker vaccine for differentiating FMD infected from vaccinated animals (DIVA) would be crucial for the control and subsequent eradication of FMD in India. In this study, we constructed a negative marker FMDV serotype O virus (vaccine strain O IND R2/1975), containing dual deletions of amino acid residues 93-143 and 10-37 in the non-structural proteins 3A and 3B, respectively through reverse genetics approach. The negative marker virus exhibited similar growth kinetics and plaque morphology in cell culture as compared to the wild type virus. In addition, we also developed and evaluated an indirect ELISA (I-ELISA) targeted to the deleted 3AB NSP region (truncated 3AB) which could be used as a companion differential diagnostic assay. The diagnostic sensitivity and specificity of the truncated 3AB I-ELISA were found to be 95.5% and 96%, respectively. The results from this study suggest that the availability negative marker virus and companion diagnostic assay could open a promising new avenue for the application of DIVA compatible marker vaccine for the control of FMD in India.
Copyright © 2015 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3A and 3B NSP; DIVA; Marker FMD virus; Reverse genetics

Mesh:

Substances:

Year:  2015        PMID: 26260689     DOI: 10.1016/j.biologicals.2015.07.004

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  3 in total

1.  Infection and protection responses of deletion mutants of non-structural proteins of foot-and-mouth disease virus serotype Asia1 in guinea pigs.

Authors:  H Lalzampuia; Subhadra Elango; Jitendra K Biswal; Narayanan Krishnaswamy; R P Tamil Selvan; P Saravanan; Priyanka Mahadappa; G R Reddy; V Bhanuprakash; Aniket Sanyal; H J Dechamma
Journal:  Appl Microbiol Biotechnol       Date:  2021-12-10       Impact factor: 4.813

2.  Development of a Blocking ELISA Using a Monoclonal Antibody to a Dominant Epitope in Non-Structural Protein 3A of Foot-and-Mouth Disease Virus, as a Matching Test for a Negative-Marker Vaccine.

Authors:  Yuanfang Fu; Pinghua Li; Yimei Cao; Na Wang; Pu Sun; Qian Shi; Xincheng Ji; Huifang Bao; Dong Li; Yingli Chen; Xingwen Bai; Xueqing Ma; Jing Zhang; Zengjun Lu; Zaixin Liu
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

Review 3.  Foot-and-Mouth Disease Virus: Immunobiology, Advances in Vaccines and Vaccination Strategies Addressing Vaccine Failures-An Indian Perspective.

Authors:  Raj Kumar Singh; Gaurav Kumar Sharma; Sonalika Mahajan; Kuldeep Dhama; Suresh H Basagoudanavar; Madhusudan Hosamani; B P Sreenivasa; Wanpen Chaicumpa; Vivek Kumar Gupta; Aniket Sanyal
Journal:  Vaccines (Basel)       Date:  2019-08-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.